Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 4, 2015-04 ,pp. : 625-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin

By Miyamura Tatsuo   Kanda Tatsuo   Nakamoto Shingo   Wu Shuang   Jiang Xia   Arai Makoto   Fujiwara Keiichi   Imazeki Fumio   Yokosuka Osamu  

Viruses, Vol. 4, Iss. 8, 2012-08 ,pp. : 1264-1278

MDPI

Access to resources Recommend Favorite

Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy

By Nakamoto Shingo   Imazeki Fumio   Arai Makoto   Yasui Shin   Nakamura Masato   Haga Yuki   Sasaki Reina   Kanda Tatsuo   Shirasawa Hiroshi   Yokosuka Osamu  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 21177-21190

MDPI

Access to resources Recommend Favorite

Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2170-2178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D‐related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 11, 2015-11 ,pp. : 1904-1912

John Wiley & Sons Inc

Access to resources Recommend Favorite